Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Maurizio Zangari

Concepts (496)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
150
2025
3049
10.030
 Why?
Thalidomide
33
2016
377
2.920
 Why?
Boronic Acids
17
2013
183
2.770
 Why?
Pyrazines
17
2013
190
2.760
 Why?
Bone Marrow
17
2022
364
1.860
 Why?
Hematopoietic Stem Cell Transplantation
21
2024
603
1.810
 Why?
Venous Thrombosis
8
2009
90
1.660
 Why?
Antineoplastic Combined Chemotherapy Protocols
31
2024
1031
1.630
 Why?
Paraproteinemias
7
2022
74
1.570
 Why?
Angiogenesis Inhibitors
12
2009
183
1.510
 Why?
Humans
164
2025
52483
1.350
 Why?
Protease Inhibitors
7
2011
61
1.310
 Why?
Chromosomes, Human, Pair 1
7
2023
96
1.280
 Why?
Proteasome Inhibitors
6
2016
104
1.240
 Why?
Prognosis
42
2025
2099
1.230
 Why?
Middle Aged
69
2025
13028
1.180
 Why?
Aged
66
2025
10121
1.170
 Why?
Neoplasm, Residual
7
2025
173
1.150
 Why?
Antibodies, Bispecific
6
2025
94
1.150
 Why?
Antineoplastic Agents
20
2024
1222
1.140
 Why?
Alkaline Phosphatase
7
2020
94
1.130
 Why?
Transplantation, Autologous
29
2024
488
1.030
 Why?
Thrombosis
6
2013
253
1.030
 Why?
Bone Remodeling
3
2016
155
1.010
 Why?
Bone Diseases
2
2021
96
1.000
 Why?
Monoclonal Gammopathy of Undetermined Significance
9
2025
125
0.960
 Why?
Male
76
2025
26761
0.930
 Why?
Female
75
2025
28171
0.920
 Why?
Osteogenesis
4
2018
366
0.910
 Why?
Gene Expression Profiling
22
2025
1105
0.880
 Why?
Immunologic Factors
5
2016
117
0.880
 Why?
Anticoagulants
6
2009
270
0.800
 Why?
Peripheral Blood Stem Cell Transplantation
6
2012
59
0.800
 Why?
Melphalan
12
2016
181
0.790
 Why?
Neoplasms, Plasma Cell
4
2024
37
0.790
 Why?
Activated Protein C Resistance
4
2011
10
0.760
 Why?
Adult
44
2025
14161
0.730
 Why?
Parathyroid Hormone
4
2018
149
0.730
 Why?
Venous Thromboembolism
3
2011
77
0.710
 Why?
Antibodies, Monoclonal
4
2022
481
0.710
 Why?
Durapatite
1
2020
23
0.680
 Why?
Plasma Cells
10
2025
239
0.680
 Why?
B-Cell Maturation Antigen
7
2025
98
0.670
 Why?
Disease-Free Survival
21
2019
460
0.650
 Why?
Gene Amplification
1
2019
58
0.650
 Why?
Thromboembolism
3
2009
52
0.640
 Why?
Aged, 80 and over
22
2025
3392
0.640
 Why?
Survival Rate
21
2020
945
0.640
 Why?
Neoplasm Proteins
7
2020
334
0.640
 Why?
Dexamethasone
14
2024
438
0.640
 Why?
Myeloablative Agonists
4
2012
32
0.630
 Why?
Retrospective Studies
25
2025
6607
0.610
 Why?
Disease Progression
17
2025
871
0.600
 Why?
Gene Expression Regulation, Neoplastic
12
2021
857
0.590
 Why?
Factor V
4
2011
11
0.590
 Why?
Oligopeptides
3
2018
92
0.590
 Why?
Bone and Bones
4
2021
494
0.590
 Why?
Spinal Fractures
1
2018
38
0.590
 Why?
Thymus Gland
1
2018
41
0.570
 Why?
Parathyroidectomy
1
2018
46
0.570
 Why?
Thyroidectomy
1
2018
61
0.560
 Why?
Translocation, Genetic
8
2021
265
0.560
 Why?
Clinical Trials as Topic
9
2022
467
0.550
 Why?
Chromosome Aberrations
11
2023
297
0.550
 Why?
Treatment Outcome
31
2022
5422
0.540
 Why?
Survival Analysis
14
2024
673
0.540
 Why?
Calcification, Physiologic
1
2017
42
0.540
 Why?
Pelvis
1
2017
69
0.530
 Why?
Follow-Up Studies
22
2024
2279
0.530
 Why?
Risk Factors
23
2024
3889
0.520
 Why?
Stem Cell Transplantation
11
2023
185
0.520
 Why?
Osteoblasts
6
2020
475
0.520
 Why?
Thrombophilia
4
2009
19
0.510
 Why?
Tumor Microenvironment
5
2024
256
0.490
 Why?
Chromosome Deletion
6
2023
142
0.470
 Why?
Drug Resistance, Neoplasm
7
2015
326
0.470
 Why?
Animals
19
2024
13505
0.450
 Why?
Neoplasms
3
2009
1325
0.450
 Why?
Transplantation Conditioning
7
2019
93
0.450
 Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
25
0.430
 Why?
Neoplasm Recurrence, Local
7
2024
649
0.430
 Why?
Polycythemia Vera
1
2013
6
0.420
 Why?
Positron-Emission Tomography
4
2025
301
0.410
 Why?
Hemostasis
3
2008
60
0.410
 Why?
Neovascularization, Pathologic
4
2009
153
0.410
 Why?
Diffusion Magnetic Resonance Imaging
3
2025
133
0.400
 Why?
Mutation
6
2022
1347
0.390
 Why?
Combined Modality Therapy
17
2024
639
0.390
 Why?
Neutropenia
2
2023
115
0.380
 Why?
Hematopoietic Stem Cells
2
2012
187
0.360
 Why?
Bone Neoplasms
2
2010
184
0.350
 Why?
Evolution, Molecular
2
2021
93
0.350
 Why?
Amyloidosis
3
2009
85
0.340
 Why?
Doxorubicin
7
2009
241
0.340
 Why?
Immunotherapy, Adoptive
4
2024
166
0.320
 Why?
Mice
11
2024
5949
0.320
 Why?
Anti-Anxiety Agents
1
2009
35
0.320
 Why?
In Situ Hybridization, Fluorescence
7
2023
263
0.320
 Why?
Kaplan-Meier Estimate
10
2019
483
0.310
 Why?
Hemorrhagic Disorders
1
2009
6
0.310
 Why?
Cryoglobulinemia
1
2008
13
0.310
 Why?
Pain
2
2009
362
0.300
 Why?
Biopsy, Needle
1
2009
183
0.300
 Why?
Analgesics
1
2009
107
0.290
 Why?
Pulmonary Embolism
1
2009
86
0.290
 Why?
Recurrence
11
2024
672
0.290
 Why?
Collagen
2
2020
211
0.290
 Why?
Risk Assessment
7
2023
1327
0.280
 Why?
Hematologic Neoplasms
2
2022
106
0.280
 Why?
Cell Line, Tumor
4
2023
1470
0.270
 Why?
Farnesyltranstransferase
1
2006
4
0.270
 Why?
Vascular Endothelial Growth Factor Receptor-2
2
2004
30
0.270
 Why?
Osteolysis
2
2022
75
0.260
 Why?
Waldenstrom Macroglobulinemia
2
2022
40
0.260
 Why?
Pyrroles
2
2004
71
0.260
 Why?
Risk
4
2014
316
0.260
 Why?
Cell Differentiation
4
2022
665
0.260
 Why?
Neoplasms, Second Primary
2
2024
77
0.260
 Why?
Cell Proliferation
8
2023
1023
0.260
 Why?
Sirolimus
1
2006
65
0.260
 Why?
Time Factors
11
2021
2968
0.260
 Why?
Logistic Models
5
2018
925
0.250
 Why?
Signal Transduction
6
2021
1671
0.250
 Why?
Chromosomes, Human, Pair 17
2
2017
35
0.240
 Why?
Fluorodeoxyglucose F18
4
2021
188
0.230
 Why?
Plasmacytoma
2
2020
43
0.230
 Why?
Immunoglobulins, Intravenous
1
2025
63
0.230
 Why?
Enoxaparin
1
2004
31
0.230
 Why?
Polycomb Repressive Complex 2
2
2021
48
0.220
 Why?
Remission Induction
10
2021
218
0.220
 Why?
Indoles
2
2004
278
0.220
 Why?
Vascular Endothelial Growth Factor A
2
2004
182
0.220
 Why?
Prospective Studies
9
2019
2481
0.200
 Why?
Blood Coagulation
1
2003
64
0.200
 Why?
Bone Resorption
2
2022
302
0.200
 Why?
Proto-Oncogene Proteins B-raf
2
2020
81
0.190
 Why?
Hematopoietic Stem Cell Mobilization
3
2008
60
0.190
 Why?
Immunoglobulin Light Chains
2
2017
90
0.190
 Why?
Immunoconjugates
1
2022
39
0.190
 Why?
Randomized Controlled Trials as Topic
3
2012
595
0.190
 Why?
Drug Approval
1
2022
46
0.190
 Why?
Cell Cycle
2
2021
230
0.190
 Why?
Hemorrhage
3
2009
209
0.190
 Why?
Lymphoma, B-Cell
1
2022
61
0.190
 Why?
Chromosomal Instability
2
2019
16
0.190
 Why?
Epigenomics
1
2021
75
0.180
 Why?
Chromosomes, Human, Pair 13
5
2008
38
0.180
 Why?
Patient Participation
1
2022
69
0.180
 Why?
SOXC Transcription Factors
1
2021
13
0.180
 Why?
T-Lymphocytes
4
2024
340
0.180
 Why?
Arkansas
5
2021
2028
0.180
 Why?
Calcium Phosphates
1
2020
5
0.170
 Why?
Odontoblasts
1
2020
4
0.170
 Why?
HL-60 Cells
1
2020
19
0.170
 Why?
U937 Cells
1
2020
15
0.170
 Why?
Etoposide
5
2009
74
0.170
 Why?
K562 Cells
1
2020
42
0.170
 Why?
Genes, Tumor Suppressor
2
2021
74
0.170
 Why?
NIH 3T3 Cells
1
2020
51
0.170
 Why?
Kidney Diseases
2
2020
220
0.170
 Why?
MCF-7 Cells
1
2020
64
0.170
 Why?
Mammals
1
2020
61
0.170
 Why?
Practice Guidelines as Topic
1
2023
488
0.170
 Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
 Why?
Leukemia, Plasma Cell
1
2020
33
0.170
 Why?
Protein C
2
2011
20
0.170
 Why?
Myelodysplastic Syndromes
3
2007
86
0.160
 Why?
beta 2-Microglobulin
5
2008
39
0.160
 Why?
HEK293 Cells
1
2020
229
0.160
 Why?
Busulfan
1
2019
17
0.160
 Why?
Cisplatin
6
2009
285
0.160
 Why?
HeLa Cells
1
2020
265
0.160
 Why?
Hematopoiesis, Extramedullary
1
2019
9
0.160
 Why?
Gene Regulatory Networks
1
2020
111
0.160
 Why?
Atrial Fibrillation
1
2022
200
0.160
 Why?
Imaging, Three-Dimensional
2
2017
154
0.160
 Why?
Epigenesis, Genetic
2
2020
406
0.160
 Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.150
 Why?
Genome-Wide Association Study
1
2020
186
0.150
 Why?
Fractures, Compression
1
2018
17
0.150
 Why?
Healthcare Disparities
1
2022
299
0.150
 Why?
Predictive Value of Tests
4
2009
944
0.150
 Why?
Spleen
1
2019
172
0.150
 Why?
Genomic Instability
2
2016
89
0.150
 Why?
Fibrinolysis
2
2009
6
0.150
 Why?
Phosphotransferases
1
2018
17
0.150
 Why?
Blood Coagulation Factors
2
2009
17
0.150
 Why?
Cytokines
3
2007
623
0.140
 Why?
Antineoplastic Agents, Alkylating
6
2008
77
0.140
 Why?
Bacteremia
1
2019
92
0.140
 Why?
Adipocytes
1
2018
132
0.140
 Why?
Cell Line
1
2020
1030
0.140
 Why?
Gene Rearrangement
1
2018
75
0.140
 Why?
Cluster Analysis
4
2012
233
0.140
 Why?
Hexokinase
1
2017
16
0.140
 Why?
Metaphase
4
2016
46
0.140
 Why?
Heparin, Low-Molecular-Weight
2
2007
21
0.140
 Why?
Ultrasonography, Doppler
2
2007
42
0.130
 Why?
Renal Insufficiency
4
2010
113
0.130
 Why?
Calcium
1
2018
376
0.130
 Why?
Fibrinolytic Agents
2
2007
128
0.130
 Why?
Clonal Evolution
1
2016
58
0.130
 Why?
Gene Expression Regulation, Enzymologic
1
2017
179
0.120
 Why?
Tumor Burden
3
2020
136
0.120
 Why?
Gene Expression
1
2018
618
0.120
 Why?
Disease Models, Animal
4
2016
1478
0.120
 Why?
Bone Marrow Transplantation
4
2022
113
0.120
 Why?
Multivariate Analysis
7
2021
591
0.120
 Why?
Tumor Suppressor Protein p53
1
2017
221
0.120
 Why?
Immunotherapy
2
2016
244
0.120
 Why?
Genes, Neoplasm
1
2015
31
0.120
 Why?
Polymorphism, Single Nucleotide
2
2020
505
0.120
 Why?
Gene Dosage
1
2015
78
0.120
 Why?
Salvage Therapy
6
2006
136
0.120
 Why?
Incidence
2
2009
1062
0.120
 Why?
Algorithms
1
2018
672
0.110
 Why?
Transcriptome
3
2025
370
0.110
 Why?
Osteoclasts
3
2022
428
0.110
 Why?
Cystatin M
2
2024
19
0.110
 Why?
Altitude
1
2013
16
0.100
 Why?
Janus Kinase 2
1
2013
25
0.100
 Why?
Case-Control Studies
4
2011
1201
0.100
 Why?
Chromosomes, Human, Pair 11
3
2020
55
0.100
 Why?
Tomography, X-Ray Computed
2
2017
1165
0.100
 Why?
Cross-Sectional Studies
3
2023
1678
0.100
 Why?
STAT3 Transcription Factor
2
2010
85
0.100
 Why?
Models, Biological
1
2016
735
0.100
 Why?
Protein-Tyrosine Kinases
3
2018
87
0.100
 Why?
Bone Density Conservation Agents
2
2010
75
0.100
 Why?
Creatinine
2
2010
150
0.100
 Why?
Cytogenetic Analysis
6
2014
80
0.100
 Why?
Mice, Inbred C57BL
1
2018
1884
0.100
 Why?
Viremia
1
2012
23
0.100
 Why?
Clone Cells
2
2023
77
0.100
 Why?
Cytomegalovirus Infections
1
2012
34
0.100
 Why?
Models, Genetic
2
2016
169
0.100
 Why?
Clinical Trials, Phase II as Topic
1
2012
47
0.090
 Why?
Clinical Trials, Phase III as Topic
1
2012
48
0.090
 Why?
Viper Venoms
1
2011
7
0.090
 Why?
Epidemiologic Methods
2
2008
46
0.090
 Why?
Drug Evaluation, Preclinical
1
2012
146
0.090
 Why?
NF-kappa B
2
2018
322
0.090
 Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.090
 Why?
Arsenicals
1
2010
15
0.090
 Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.090
 Why?
Oxides
1
2010
21
0.090
 Why?
Mutation Rate
2
2021
36
0.090
 Why?
Granulocyte Colony-Stimulating Factor
2
2008
64
0.090
 Why?
Hypercalcemia
1
2010
34
0.090
 Why?
Transplantation, Homologous
4
2003
150
0.090
 Why?
Cyclophosphamide
4
2003
171
0.090
 Why?
Janus Kinase 1
1
2010
16
0.080
 Why?
Antineoplastic Agents, Hormonal
2
2007
53
0.080
 Why?
Anemia
1
2010
74
0.080
 Why?
MAP Kinase Kinase 1
1
2010
23
0.080
 Why?
Cyclin-Dependent Kinases
1
2010
26
0.080
 Why?
Proteinuria
1
2010
39
0.080
 Why?
Administration, Oral
2
2009
451
0.080
 Why?
Genomics
2
2023
268
0.080
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
82
0.080
 Why?
Alleles
2
2021
276
0.080
 Why?
Diphosphonates
1
2010
92
0.080
 Why?
Lorazepam
1
2009
12
0.080
 Why?
Receptors, Retinoic Acid
1
2009
22
0.080
 Why?
Dose-Response Relationship, Drug
3
2008
1378
0.080
 Why?
Hyperhomocysteinemia
1
2009
29
0.080
 Why?
Oxycodone
1
2009
26
0.080
 Why?
Anesthesia, Local
1
2009
17
0.080
 Why?
Prednisone
1
2009
102
0.080
 Why?
Histones
2
2021
314
0.080
 Why?
Tretinoin
1
2009
54
0.080
 Why?
Hemostatic Techniques
1
2009
28
0.080
 Why?
Plasma Exchange
1
2009
25
0.080
 Why?
Vasculitis
1
2008
29
0.080
 Why?
Vincristine
3
2003
88
0.080
 Why?
Transcription Factors
2
2023
566
0.080
 Why?
Syndecan-1
3
2021
74
0.080
 Why?
Biopsy
3
2018
605
0.070
 Why?
DNA Copy Number Variations
2
2021
117
0.070
 Why?
Bone Development
1
2009
66
0.070
 Why?
Drug Therapy, Combination
1
2009
395
0.070
 Why?
Cytogenetics
1
2008
23
0.070
 Why?
Radiopharmaceuticals
2
2021
204
0.070
 Why?
Carrier Proteins
1
2010
313
0.070
 Why?
Pain Measurement
1
2009
256
0.070
 Why?
Platelet Aggregation
1
2008
72
0.070
 Why?
Thrombocytopenia
1
2009
89
0.070
 Why?
Staphylococcal Infections
2
2019
285
0.070
 Why?
Double-Blind Method
1
2009
713
0.070
 Why?
Brain Diseases, Metabolic
1
2007
5
0.070
 Why?
Phlebography
1
2007
55
0.070
 Why?
Hyperammonemia
1
2007
24
0.070
 Why?
Myeloma Proteins
1
2007
26
0.070
 Why?
Antimetabolites
1
2006
12
0.070
 Why?
Chi-Square Distribution
1
2007
288
0.070
 Why?
Cell Communication
2
2023
71
0.070
 Why?
Partial Thromboplastin Time
1
2006
13
0.070
 Why?
Magnetic Resonance Imaging
4
2007
1546
0.070
 Why?
Osteoprotegerin
1
2006
53
0.060
 Why?
Heterozygote
1
2006
90
0.060
 Why?
Acetaminophen
1
2009
279
0.060
 Why?
Antibiotics, Antineoplastic
1
2006
80
0.060
 Why?
Gastrointestinal Neoplasms
1
2006
42
0.060
 Why?
Models, Statistical
1
2007
230
0.060
 Why?
Pilot Projects
1
2008
721
0.060
 Why?
Age Factors
3
2005
1132
0.060
 Why?
Femur Head Necrosis
1
2005
17
0.060
 Why?
Neovascularization, Physiologic
1
2005
72
0.060
 Why?
Apoptosis
1
2010
1119
0.060
 Why?
Gene Deletion
2
2003
272
0.060
 Why?
Syndrome
2
2019
247
0.060
 Why?
ROC Curve
1
2025
253
0.060
 Why?
Ferritins
1
2024
36
0.050
 Why?
Killer Cells, Natural
1
2024
116
0.050
 Why?
Glucuronidase
1
2003
47
0.050
 Why?
Myeloid Progenitor Cells
1
2023
17
0.050
 Why?
X-Ray Microtomography
1
2024
79
0.050
 Why?
CD8-Positive T-Lymphocytes
1
2024
132
0.050
 Why?
Receptors, G-Protein-Coupled
1
2024
56
0.050
 Why?
DNA Methylation
2
2020
592
0.050
 Why?
DNA, Neoplasm
2
2020
146
0.050
 Why?
Antibodies
1
2024
159
0.050
 Why?
Immunosuppressive Agents
1
2005
243
0.050
 Why?
Discitis
1
2003
10
0.050
 Why?
Oligonucleotide Array Sequence Analysis
4
2006
405
0.050
 Why?
Myeloproliferative Disorders
1
2003
31
0.050
 Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
 Why?
Antigens, CD34
1
2003
72
0.050
 Why?
Tumor Cells, Cultured
3
2010
460
0.050
 Why?
Platelet Count
3
2008
75
0.050
 Why?
Rats
1
2009
3220
0.050
 Why?
Patients
1
2022
51
0.050
 Why?
Geography
1
2022
65
0.050
 Why?
Leukemia, Myeloid
1
2002
42
0.050
 Why?
Myeloid Differentiation Factor 88
1
2022
34
0.050
 Why?
Receptors, Antigen, T-Cell
1
2022
54
0.050
 Why?
Drug Interactions
1
2002
206
0.050
 Why?
Chromosome Disorders
1
2002
32
0.050
 Why?
Patient Selection
1
2023
259
0.050
 Why?
United States Food and Drug Administration
1
2022
98
0.050
 Why?
Oncogenes
1
2021
60
0.050
 Why?
Enzyme Inhibitors
1
2004
372
0.050
 Why?
Phylogeny
1
2022
231
0.050
 Why?
Hypothyroidism
1
2002
57
0.050
 Why?
Central Nervous System Neoplasms
1
2002
68
0.050
 Why?
RANK Ligand
1
2022
187
0.040
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2022
91
0.040
 Why?
Transcriptional Activation
1
2021
122
0.040
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2022
106
0.040
 Why?
Chromatin
1
2021
139
0.040
 Why?
Cohort Studies
2
2020
1542
0.040
 Why?
Pyrimidines
1
2022
199
0.040
 Why?
Cyclin D2
1
2020
21
0.040
 Why?
Proto-Oncogene Proteins p21(ras)
1
2021
69
0.040
 Why?
Endothelium, Vascular
1
2002
246
0.040
 Why?
Aneuploidy
1
2020
18
0.040
 Why?
Antibodies, Monoclonal, Humanized
1
2022
236
0.040
 Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
 Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
 Why?
ras Proteins
1
2020
64
0.040
 Why?
Histone Code
1
2020
32
0.040
 Why?
Cyclin D1
1
2020
57
0.040
 Why?
Gene Expression Regulation, Leukemic
1
2020
32
0.040
 Why?
Genome, Human
1
2021
121
0.040
 Why?
Chromosomes, Human, Pair 14
1
2020
75
0.040
 Why?
Longitudinal Studies
2
2016
747
0.040
 Why?
Transcriptional Elongation Factors
1
2020
17
0.040
 Why?
Protein Kinase Inhibitors
1
2022
227
0.040
 Why?
Genetic Loci
1
2020
49
0.040
 Why?
Postoperative Complications
1
2007
1068
0.040
 Why?
DNA Mutational Analysis
1
2020
180
0.040
 Why?
RNA, Messenger
3
2010
1132
0.040
 Why?
Genetic Variation
1
2020
230
0.040
 Why?
Health Status Disparities
1
2022
215
0.040
 Why?
High-Throughput Nucleotide Sequencing
1
2020
182
0.040
 Why?
Neoplastic Stem Cells
2
2015
99
0.040
 Why?
Computational Biology
1
2020
212
0.040
 Why?
Gram-Positive Bacterial Infections
1
2019
30
0.040
 Why?
Proline
1
2018
31
0.040
 Why?
Pseudomonas Infections
1
2019
54
0.040
 Why?
Bone Marrow Cells
2
2014
190
0.040
 Why?
DNA-Binding Proteins
1
2021
422
0.040
 Why?
Recombinant Proteins
2
2010
483
0.040
 Why?
Promoter Regions, Genetic
1
2020
467
0.040
 Why?
Fluorescent Dyes
1
2018
105
0.040
 Why?
Receptor Protein-Tyrosine Kinases
1
2018
52
0.040
 Why?
Proteolysis
1
2018
101
0.040
 Why?
Oncogene Proteins, Fusion
1
2018
61
0.040
 Why?
Extracellular Matrix
1
2018
112
0.040
 Why?
Kidney Function Tests
1
2017
54
0.030
 Why?
Cell Movement
1
2018
268
0.030
 Why?
False Positive Reactions
1
2017
63
0.030
 Why?
Glomerular Filtration Rate
1
2017
124
0.030
 Why?
Amino Acid Sequence
1
2018
578
0.030
 Why?
Genetic Predisposition to Disease
1
2020
528
0.030
 Why?
Cell Survival
2
2010
612
0.030
 Why?
Genes, ras
1
2016
43
0.030
 Why?
Genes, p53
1
2016
52
0.030
 Why?
Mice, SCID
2
2009
182
0.030
 Why?
Glycolysis
1
2016
73
0.030
 Why?
Chromosome Mapping
2
2006
154
0.030
 Why?
Image Interpretation, Computer-Assisted
1
2016
107
0.030
 Why?
Phosphatidylinositol 3-Kinases
1
2016
151
0.030
 Why?
Serum Albumin
2
2008
58
0.030
 Why?
Syndecans
2
2006
37
0.030
 Why?
Proteoglycans
2
2006
87
0.030
 Why?
Cells, Cultured
1
2018
1567
0.030
 Why?
Drug Monitoring
1
2015
83
0.030
 Why?
Myocardium
1
2017
453
0.030
 Why?
Interspersed Repetitive Sequences
1
2014
7
0.030
 Why?
Karyotype
1
2014
19
0.030
 Why?
Proportional Hazards Models
2
2006
443
0.030
 Why?
Membrane Glycoproteins
2
2006
244
0.030
 Why?
Transplantation Chimera
2
2003
16
0.020
 Why?
Neoplasm Staging
2
2007
772
0.020
 Why?
Infusions, Intravenous
2
2003
220
0.020
 Why?
RNA Interference
1
2013
181
0.020
 Why?
Cytomegalovirus
1
2012
29
0.020
 Why?
Viral Load
1
2012
82
0.020
 Why?
Virus Activation
1
2012
39
0.020
 Why?
Graft vs Host Disease
2
2003
87
0.020
 Why?
United States
1
2022
5192
0.020
 Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
 Why?
Cell Growth Processes
1
2010
22
0.020
 Why?
Antiviral Agents
1
2012
178
0.020
 Why?
CDC2-CDC28 Kinases
1
2010
11
0.020
 Why?
Femur
1
2010
135
0.020
 Why?
Long-Term Care
1
2010
51
0.020
 Why?
RNA, Small Interfering
1
2010
213
0.020
 Why?
Peripheral Nervous System Diseases
1
2010
59
0.020
 Why?
Down-Regulation
1
2010
346
0.020
 Why?
Bone Diseases, Metabolic
1
2010
78
0.020
 Why?
Abnormalities, Multiple
1
2010
166
0.020
 Why?
Cell Transformation, Neoplastic
1
2010
184
0.020
 Why?
Protein Isoforms
1
2009
123
0.020
 Why?
Ploidies
1
2008
10
0.020
 Why?
Ligands
1
2009
206
0.020
 Why?
Polyethylene Glycols
1
2008
90
0.020
 Why?
Rabbits
1
2009
375
0.020
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2009
582
0.020
 Why?
Hemoglobins
1
2008
112
0.020
 Why?
Age Distribution
1
2007
174
0.020
 Why?
C-Reactive Protein
1
2008
155
0.020
 Why?
Diagnosis, Differential
1
2010
1046
0.020
 Why?
Ammonia
1
2007
86
0.020
 Why?
Mass Screening
1
2010
357
0.020
 Why?
Multigene Family
1
2006
48
0.020
 Why?
Blood Proteins
1
2007
85
0.020
 Why?
Cyclin D
1
2006
18
0.020
 Why?
Brain
2
2007
1323
0.020
 Why?
Bone Density
1
2009
399
0.020
 Why?
Cyclins
1
2006
38
0.020
 Why?
Evidence-Based Medicine
1
2007
261
0.020
 Why?
RNA, Neoplasm
1
2006
45
0.020
 Why?
Radiography
1
2007
470
0.020
 Why?
Coculture Techniques
1
2006
144
0.020
 Why?
Leukemia, Myeloid, Acute
1
2007
203
0.020
 Why?
Data Interpretation, Statistical
1
2006
164
0.020
 Why?
Neoplasms, Experimental
1
2006
114
0.020
 Why?
Interferon-alpha
1
2005
53
0.010
 Why?
Survivors
1
2006
120
0.010
 Why?
Mice, Transgenic
1
2006
552
0.010
 Why?
Databases, Factual
1
2007
706
0.010
 Why?
Monosomy
1
2003
5
0.010
 Why?
Odds Ratio
1
2005
558
0.010
 Why?
Trisomy
1
2003
35
0.010
 Why?
Endothelial Growth Factors
1
2003
9
0.010
 Why?
History, 21st Century
1
2003
59
0.010
 Why?
Vascular Endothelial Growth Factors
1
2003
14
0.010
 Why?
Lymphokines
1
2003
20
0.010
 Why?
Fusion Proteins, bcr-abl
1
2003
20
0.010
 Why?
History, 20th Century
1
2003
96
0.010
 Why?
Stem Cell Factor
1
2003
7
0.010
 Why?
Lymphocyte Transfusion
1
2003
10
0.010
 Why?
Confidence Intervals
1
2003
158
0.010
 Why?
Interphase
1
2003
10
0.010
 Why?
Probability
1
2003
172
0.010
 Why?
Diploidy
1
2003
25
0.010
 Why?
Leukocyte Count
1
2003
73
0.010
 Why?
Back Pain
1
2003
39
0.010
 Why?
Interferons
1
2002
40
0.010
 Why?
Sex Factors
1
2005
727
0.010
 Why?
Cell Count
1
2003
149
0.010
 Why?
Intercellular Signaling Peptides and Proteins
1
2003
105
0.010
 Why?
Drug Administration Schedule
1
2003
374
0.010
 Why?
Thyroid Function Tests
1
2002
27
0.010
 Why?
Thyrotropin
1
2002
49
0.010
 Why?
Prevalence
1
2005
1006
0.010
 Why?
Fatal Outcome
1
2002
197
0.010
 Why?
Neutrophils
1
2003
147
0.010
 Why?
Tissue Donors
1
2003
126
0.010
 Why?
Cell Division
1
2002
291
0.010
 Why?
Reoperation
1
2003
465
0.010
 Why?
Acute Disease
1
2002
373
0.010
 Why?
Up-Regulation
1
2002
454
0.010
 Why?
Anti-Bacterial Agents
1
2003
807
0.010
 Why?
Zangari's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (496) concept(s)
_
Co-Authors Expand Description
See all (48) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department